TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32559607

Group type: COMPARATOR
Intervention: Published trials funded by NIH/US Federal Government
Number of subjects: 1389

Group type: COMPARATOR
Intervention: Published trials funded by other non-industry organizations
Number of subjects: 1389

Group type: COMPARATOR
Intervention: Published trials with procedural intervention
Number of subjects: 1389

Group type: COMPARATOR
Intervention: Published trials with enrollment of >150
Number of subjects: 1389
Study: 34774867

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1.5 mA for 20 min)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Anodal tDCS (1.5 mA for 20 min)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 56
Study: 33307857

Group type: EXPERIMENTAL
Intervention: Telemedicine group (monitoring and data transmission twice per day, telephone call, and 2 home visits)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (daily visits)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Telemedicine group
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116
Study: 35211797

Group type: EXPERIMENTAL
Intervention: Azithromycin (3 days) with initial corticosteroid course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 32398420

Group type: EXPERIMENTAL
Intervention: Omalizumab (300 mg fixed dose or dose-related based on total IgE level and body mass weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 35084903

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for CUD
Number of subjects: 302
Study: 33285332

Group type: EXPERIMENTAL
Intervention: Biperiden (antagonist of muscarinic receptors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amisulpride (antagonist of dopaminergic receptors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Galantamine (enhancing drug of cholinergic modulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35795593

Group type: EXPERIMENTAL
Intervention: 2% Sodium Hyaluronate (SH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (without SH)
Number of subjects: 30
Study: 33395210

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg (oral and/or intravenous) once daily for 6 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active comparator (selected by investigator from an allowed list) for 10 days
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active comparator
Number of subjects: 120
Study: 34238836

Group type: EXPERIMENTAL
Intervention: Nursing process software
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine hospital protocol
Number of subjects: 80
Study: 32546177

Group type: EXPERIMENTAL
Intervention: ANtiPain intervention (face-to-face in-hospital session by a trained nurse and follow-up phone calls)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: ANtiPain intervention
Number of subjects: 153
Study: 34261828

Group type: EXPERIMENTAL
Intervention: Resolute Onyx zotarolimus‐eluting stent (RO‐ZES)
Number of subjects: 2488

Group type: COMPARATOR
Intervention: Orsiro sirolimus‐eluting stent (O‐SES)
Number of subjects: 2488
Study: 33275561

Group type: EXPERIMENTAL
Intervention: Parent-reported sleep patterns at age 2.5 yr
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Longer settling times at age 2.5 yr
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Longer settling times from ages 6 mo to 2.5 yr
Number of subjects: 160
Study: 35609525

Group type: EXPERIMENTAL
Intervention: Reflexology (once a week for 6 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (routine maintenance of the chemotherapy unit)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Reflexology and Control
Number of subjects: 58
Study: 33813855

Group type: EXPERIMENTAL
Intervention: Hypertension label
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: High-normal BP label
Number of subjects: 1318

Group type: COMPARATOR
Intervention: Control (general BP description)
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Providing absolute risk information in the hypertension group
Number of subjects: 1318
Study: 33095779

Group type: EXPERIMENTAL
Intervention: PHQ-9 cut-off score for people with type 2 diabetes
Number of subjects: 315

Group type: COMPARATOR
Intervention: PHQ-9 cut-off score for people without diabetes
Number of subjects: 315

Group type: COMPARATOR
Intervention: Two-stage method for people without diabetes
Number of subjects: 315
Study: 36204969

Group type: EXPERIMENTAL
Intervention: 0.5% silymarin-loaded antioxidant serum (SAS) applied twice daily for 4 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.5% silymarin-loaded antioxidant serum (SAS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.5% silymarin-loaded antioxidant serum (SAS) with low-dose oral isotretinoin
Number of subjects: 22
Study: 33260141

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (0.09 g/kg providing 3 mg/kg of caffeine)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 32933954

Group type: EXPERIMENTAL
Intervention: Food-related behavioural activation (F-BA) therapy
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Nutritional supplements
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 1025

Group type: COMPARATOR
Intervention: No behavioural intervention
Number of subjects: 1025
Study: 33471625

Group type: EXPERIMENTAL
Intervention: 20 g/d of milk protein concentrate
Number of subjects: 25

Group type: COMPARATOR
Intervention: Isocaloric carbohydrate placebo
Number of subjects: 25
Study: 32435005

Group type: EXPERIMENTAL
Intervention: Tafluprost eye drop (0.015%) applied to one eye (miosis group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (mydriasis group)
Number of subjects: 0
Study: 35088499

Group type: COMPARATOR
Intervention: Conventional treatment (systemic immunosuppressant, antihistamine, calcium gluconate, topical salicylic acid)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus supplemental essential phospholipids (EPL)
Number of subjects: 132
Study: 34290085

Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block (20 mL of adrenalized levobupivacaine 0.50%)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suprainguinal fascia iliaca block (40 mL of adrenalized levobupivacaine 0.25%)
Number of subjects: 40
Study: 36118104

Group type: EXPERIMENTAL
Intervention: Wearing the Serola Sacroiliac Belt during a 10-minute daily repeated strenuous lifting task
Number of subjects: 33

Group type: COMPARATOR
Intervention: Not wearing the Serola Sacroiliac Belt during the same lifting task
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Wearing the Serola Sacroiliac Belt
Number of subjects: 33

Group type: COMPARATOR
Intervention: Not wearing the Serola Sacroiliac Belt
Number of subjects: 33
Study: 32586259

Group type: EXPERIMENTAL
Intervention: QSPR models using backward‐multiple linear regression (MLR) and genetic algorithm (GA‐MLR) for descriptor selection
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: QSPR models with five descriptors in three blocks: connectivity, edge adjacency indices, and 2D matrix‐based descriptors
Number of subjects: 91
Study: 34961705

Group type: EXPERIMENTAL
Intervention: 200 mg roscovitine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 400 mg roscovitine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 800 mg roscovitine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32896349

Group type: EXPERIMENTAL
Intervention: Ultrasonography for assessing costal cartilage calcification
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ultrasonography for assessing honeycombed phenomenon
Number of subjects: 65
Study: 34845507

Group type: EXPERIMENTAL
Intervention: Anticoagulant prophylaxis (not specified dosage or duration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring for signs of VTE after laparoscopic surgery
Number of subjects: 0
Study: 33619809

Group type: EXPERIMENTAL
Intervention: Electric sonic device
Number of subjects: 12

Group type: COMPARATOR
Intervention: Manual cleansing
Number of subjects: 12
Study: 36480569

Group type: EXPERIMENTAL
Intervention: Alive & Thrive's IYCF social and behavior change communication intervention
Number of subjects: 6326

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6326
Study: 34633753

Group type: EXPERIMENTAL
Intervention: Lubiprostone (24 mcg twice daily)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 32678852

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (CNP)
Number of subjects: 4846

Group type: COMPARATOR
Intervention: Physical activity intervention (PA)
Number of subjects: 4846

Group type: COMPARATOR
Intervention: Nutrition education intervention (NE)
Number of subjects: 4846
Study: 35879756

Group type: EXPERIMENTAL
Intervention: Autogenic Inhibition (AI) technique with Conventional therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Reciprocal Inhibition (RI) technique with Conventional therapy
Number of subjects: 80
Study: 33524684

Group type: EXPERIMENTAL
Intervention: Philadelphia cervical collar
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Miami‐J cervical collar
Number of subjects: 2
Study: 32822827

Group type: EXPERIMENTAL
Intervention: asthma education + home environment remediation + school intervention
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: asthma education + home environment remediation
Number of subjects: 300

Group type: COMPARATOR
Intervention: comparator condition
Number of subjects: 300
Study: 36326931

Group type: EXPERIMENTAL
Intervention: Surgery Group (SG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endoscopy Group (EG)
Number of subjects: 30
Study: 35092016

Group type: EXPERIMENTAL
Intervention: Program for the Education in Enrichment of Relational Skills (PEERS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 34708460

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg daily)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 124
Study: 33782836

Group type: EXPERIMENTAL
Intervention: Ampreloxetine (10 mg once daily)
Number of subjects: 34
Study: 32068002

Group type: EXPERIMENTAL
Intervention: Elamipretide 4 mg once daily for 28 days
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Elamipretide 40 mg once daily for 28 days
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 32631173

Group type: EXPERIMENTAL
Intervention: OPD structural integration
Number of subjects: 719
Study: 33668937

Group type: EXPERIMENTAL
Intervention: Plyometric training (PLY)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 17
Study: 37885327

Group type: EXPERIMENTAL
Intervention: Mindfulness-based psychoeducation program (twice a week for 4 weeks via video conference)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study: 34291443

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1g IV at surgery initiation and 500mg orally every 8 hours for 3 days)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo (starch capsules)
Number of subjects: 108
Study: 32219526

Group type: EXPERIMENTAL
Intervention: Intratympanic (IT) steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intratympanic (IT) gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (IT steroids)
Number of subjects: 0
Study: 33397664

Group type: EXPERIMENTAL
Intervention: App Tät (3 months use)
Number of subjects: 2672

Group type: EXPERIMENTAL
Intervention: Weighted results to match RCT severity distribution
Number of subjects: 2672

Group type: COMPARATOR
Intervention: RCT
Number of subjects: 2672
Study: 32945774

Group type: EXPERIMENTAL
Intervention: WeChat users
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: WeChat-based mHealth program endorsement
Number of subjects: 400
Study: 35927645

Group type: EXPERIMENTAL
Intervention: PEEK cages
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: TC-PEEK cages
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Implant-to-bone surface ratio
Number of subjects: 104
Study: 35524188

Group type: EXPERIMENTAL
Intervention: Cognitive training (A)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Physical training (B)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Combined cognitive and physical training (C)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Mixed ABC, A + B, C + A, B + C (various combinations of cognitive and physical training)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 285
Study: 33603039

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (Menstrual Phase Effects)
Number of subjects: 14
Study: 35398573

Group type: EXPERIMENTAL
Intervention: Low-budget exoscope
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional binocular microscope
Number of subjects: 16
Study: 33372062

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sleep-deprived wakefulness
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Non-rapid eye movement sleep
Number of subjects: 76
Study: 33532608

Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT) for 4 weeks, exercising 3 times a week on a cycle ergometer, achieving ≥ 90% max heart rate during each exercise session.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exercise (control group) for 4 weeks, receiving additional advice on hypoglycaemia avoidance.
Number of subjects: 0
Study: 32553191

Group type: EXPERIMENTAL
Intervention: 1.5% olanexidine
Number of subjects: 587

Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 587
Study: 36206636

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (15,000 IU)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 33787519

Group type: EXPERIMENTAL
Intervention: Bern classification system
Number of subjects: 42

Group type: COMPARATOR
Intervention: Beck classification
Number of subjects: 42

Group type: COMPARATOR
Intervention: Konan classification
Number of subjects: 42

Group type: COMPARATOR
Intervention: Outerbridge classification
Number of subjects: 42

Group type: COMPARATOR
Intervention: Peters classification
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lage classification
Number of subjects: 42

Group type: COMPARATOR
Intervention: Beck classification for labral lesions
Number of subjects: 42
Study: 32347147

Group type: EXPERIMENTAL
Intervention: ECPR
Number of subjects: 129736
Study: 35264713

Group type: COMPARATOR
Intervention: Routine therapeutic program
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined respiratory exercises with routine therapeutic program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33218309

Group type: EXPERIMENTAL
Intervention: Photo‐Integrated Conversation Moderated by Robots (PICMOR) intervention
Number of subjects: 61
Study: 32713109

Group type: EXPERIMENTAL
Intervention: 250 mg of azithromycin 3 times weekly for 4 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 32005336

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive behavior therapy (CBT)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Disorder-specific cognitive behavior therapy (CBT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: CBT (both transdiagnostic and disorder-specific)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Treatment (CBT)
Number of subjects: 223
Study: 36471362

Group type: EXPERIMENTAL
Intervention: Combination of three-dimensional visualization technology with the PBL teaching mode
Number of subjects: 106

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 106
Study: 34340917

Group type: EXPERIMENTAL
Intervention: Volumetric contouring protocol
Number of subjects: 327

Group type: COMPARATOR
Intervention: Anatomical contouring protocol
Number of subjects: 327
Study: 33164281

Group type: EXPERIMENTAL
Intervention: Running exercises at 30% HRR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Running exercises at 60% HRR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 32325005

Group type: EXPERIMENTAL
Intervention: Home monitoring program (including home spirometry, reporting of symptoms and side effects, patient-reported outcomes, information, a medication coach, and eConsultations)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Home monitoring program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 90
Study: 35830893

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus polychemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polychemotherapy alone (control)
Number of subjects: 0
Study: 34597872

Group type: EXPERIMENTAL
Intervention: Raising doubt about desirable anticipated consequences of suicide in a virtual reality (VR) setting.
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Raising doubt about the anticipated consequences of attempting suicide by firearm.
Number of subjects: 639

Group type: COMPARATOR
Intervention: Anticipated consequence manipulation (control condition).
Number of subjects: 639
Study: 35029629

Group type: EXPERIMENTAL
Intervention: Subcutaneous casirivimab and imdevimab, 1200 mg (600 mg of each)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 32589451

Group type: EXPERIMENTAL
Intervention: NRTIs tenofovir alafenamide (TAF)/FTC
Number of subjects: 77590

Group type: EXPERIMENTAL
Intervention: NRTIs tenofovir disoproxil fumarate (TDF)/FTC
Number of subjects: 77590

Group type: EXPERIMENTAL
Intervention: NRTIs abacavir (ABC)/lamivudine (3TC)
Number of subjects: 77590

Group type: EXPERIMENTAL
Intervention: Other regimens
Number of subjects: 77590
Study: 34995536

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: COMPARATOR
Intervention: TDF vs placebo
Number of subjects: 119

Group type: COMPARATOR
Intervention: TDF and placebo
Number of subjects: 119
Study: 34464237

Group type: EXPERIMENTAL
Intervention: PEEP titrated to end‐expiratory transpulmonary pressure near 0 cm H2O
Number of subjects: 200
Study: 32133931

Group type: EXPERIMENTAL
Intervention: Incentive group ($10/day maximum for providing blood samples with reduced or undetectable viral load)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual Care group (no incentives)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual Care group
Number of subjects: 102
Study: 35638533

Group type: EXPERIMENTAL
Intervention: 100 mg of rectal diclofenac every 12 hours plus 30 mg of intramuscular pentazocine every 6 hours (group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 60 mg of intramuscular pentazocine every 6 hours (group B)
Number of subjects: 200
Study: 34132880

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 16
Study: 36030815

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Weight training program
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cameron's stage four sexual maturation participants
Number of subjects: 26
Study: 32761069

Group type: EXPERIMENTAL
Intervention: D‐PRESCRIBE intervention (pharmacist-led education)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D‐PRESCRIBE intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35903378

Group type: EXPERIMENTAL
Intervention: Low-intensive intervention group (traditional and mHealth occupational health education)
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: High-intensive intervention group (low-intensive group activities and peer education)
Number of subjects: 1211

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1211
Study: 32979724

Group type: EXPERIMENTAL
Intervention: Mediterranean diet enriched with fatty fish (2 meals/week, ≥150 g cooked filleted fish/meal)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 64
Study: 35119198

Group type: EXPERIMENTAL
Intervention: Decontextualisation test involving logical reasoning problems
Number of subjects: 52
Study: 35264990

Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg perioperative oral)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 52
Study: 32556857

Group type: EXPERIMENTAL
Intervention: CAUTI cases
Number of subjects: 1045
Study: 35555638

Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Gatorade (GAT)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Milk permeate solution (GoodSport, GS)
Number of subjects: 4
Study: 32213126

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exercise (VRE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Traditional Exercise (TE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 80
Study: 35586982

Group type: EXPERIMENTAL
Intervention: Dehydrated cell and protein concentrate (dCPC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Corticosteroid (CSI)
Number of subjects: 51
Study: 33231919

Group type: EXPERIMENTAL
Intervention: Chronic stress (administered via four distinct anthropogenic stressors for 30 minutes daily for 21 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-stressed birds)
Number of subjects: 0
Study: 32956419

Group type: EXPERIMENTAL
Intervention: Early HAART (started within 5 days of ICU admission)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Late HAART (started after discharge from the ICU)
Number of subjects: 115